Sign In
Buy CERT
$5.60
-0.0200 (-0.356%)
At Close: Jun 03, 2026
Alpha Wave Global LP Takes Position in Certara, Inc. $CERT
03:05am, Saturday, 14'th Mar 2026
Alpha Wave Global LP acquired a new position in Certara, Inc. (NASDAQ: CERT) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. T
Certara, Inc. (CERT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
03:20pm, Tuesday, 10'th Mar 2026
Certara, Inc. (CERT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Certara, Inc. (CERT) Presents at Leerink Global Healthcare Conference 2026 Transcript
10:28am, Monday, 09'th Mar 2026
Certara, Inc. (CERT) Presents at Leerink Global Healthcare Conference 2026 Transcript
Certara CEO Resnick Teases Regulatory Services Decision, Phoenix Cloud Push at TD Cowen Conference
02:34am, Monday, 09'th Mar 2026
Certara (NASDAQ: CERT) executives used a fireside chat at the TD Cowen Health Care Conference to outline early priorities under new CEO Jon Resnick, discuss the company's ongoing strategic review of i
Certara, Inc. (CERT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
06:12pm, Tuesday, 03'rd Mar 2026
Certara, Inc. (CERT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
08:00am, Tuesday, 03'rd Mar 2026
RADNOR, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced its Simcyp® Simulator enabled physiologically-based p
Touchstone Small Cap Fund Q4 2025 Portfolio Review
07:20am, Monday, 02'nd Mar 2026
The Touchstone Small Cap Fund (Class A Shares, Load Waived) outperformed its benchmark, the Russell 2000® Index, for the quarter ended December 31, 2025. The best performing stocks based on relative
Certara to Participate in Upcoming Investor Conferences
08:30am, Friday, 27'th Feb 2026
RADNOR, Pa., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the followi
Certara, Inc. (CERT) Q4 2025 Earnings Call Transcript
01:37pm, Thursday, 26'th Feb 2026
Certara, Inc. (CERT) Q4 2025 Earnings Call Transcript
Certara, Inc. (CERT) Q4 Earnings Lag Estimates
09:15am, Thursday, 26'th Feb 2026
Certara, Inc. (CERT) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.15 per share a year ago.
Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance
06:00am, Thursday, 26'th Feb 2026
FY 2025 Revenue of $418.8M (9% growth) and Adj. EBITDA of $134.5M (10% growth) Fourth Quarter Revenue of $103.6M (3% growth) and Adj.
The London Company Small Cap Q4 2025 Performance And Trades
09:27am, Tuesday, 17'th Feb 2026
The London Company Small Cap portfolio increased 2.7% (2.5% net) during the quarter vs. a 2.2% increase in the Russell 2000 Index. Contributors to relative performance were White Mountains Insurance G
Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025
08:30am, Thursday, 29'th Jan 2026
RADNOR, Pa., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth q
Wasatch Core Growth Fund Q4 2025 Performance Review
10:10am, Tuesday, 27'th Jan 2026
Shift4 Payments' stock was down after a competitor reported disappointing results, raising concerns for the industry. While Trex Co. is facing some current challenges, we still view Trex as a high-qua
Cerrado Gold Inc. (CERT:CA) Discusses Purported Unfavourable Opinion of Environmental Impact Assessment for Lagoa Salgada Project Transcript
